CRF is pleased to sponsor its first-ever Technology and Heart Failure Therapeutics conference, THT 2022. Given the growing prevalence of heart failure worldwide, we recognize a clear mandate for developing new monitoring strategies and treatment options to increase survival, decrease hospitalizations, and improve quality of life — and for achieving these goals via a variety of potential interventions that target the various contributors to heart failure.

Event Contact
Address: New York Marriott Marquis, New York, USA
Medical & Pharma, Science & Research, Business Services, Education & Training
Heart disease is the leading cause of death for both men and women in the U.S. and worldwide. Each year, more than 600,000 Americans die of heart disease representing nearly a quarter of all deaths. The number of Americans diagnosed with heart disease is currently 26.6 million, more than 11% of the population.
Sign in to your account